Germany · 
What does Global Life Science Ventures invest in?
Global Life Science Ventures invests most often at Series B and Series C (50% of the rounds on record), in sectors such as Manufacturing, Software and Venture Capital & Private Equity.
Global Life Science Ventures highlights
- 01
22 rounds on record
- 02
Mostly Series B and Series C: 50% of its rounds
- 03
7 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- ManufacturingSoftwareVenture Capital & Private Equity
- Based in
- Muenchen, Germany
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first22 appearances
- 2015
1 round
- Jan
- 2014
1 round
- Nov
- 2012
1 round
- Jun
- 2010
1 round
- Jul
- 2009
2 rounds
- Dec
- Sept
- 2008
1 round
- Mar
- 2007
4 rounds
- Dec
- Aug
- Mar
- Mar
- 2006
2 rounds
- Nov
- Oct
- 2005
1 round
- Dec
- 2004
2 rounds
- Mar
- Mar
- 2003
4 rounds
- Nov
- Aug
- Jul
- Jul
- 2002
2 rounds
- Nov
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed7 in all
Santaris PharmaBought by Roche$450MAug 2014
IntercellBought by VivalisUndisclosedDec 2012
Coapt SystemsBought by MicroAireUndisclosedAug 2010
Coley Pharmaceutical GroupBought by PfizerUndisclosedNov 2007
NeurogesXListedUndisclosedFeb 2007
CareX SABought by 7TM PharmaUndisclosedMay 2006
Glycart Biotechnology AGBought by RocheUndisclosedJul 2005
An exit counts when it came after the firm's first round in the company. From historical deal records.